Global Vision Impairment and Blindness Due to Uncorrected Refractive Error, 1990–2010

The purpose of this systematic review was to estimate worldwide the number of people with moderate and severe visual impairment (MSVI; presenting visual acuity <6/18, ≥3/60) or blindness (presenting visual acuity <3/60) due to uncorrected refractive error (URE), to estimate trends in prevalenc...

Full description

Saved in:
Bibliographic Details
Published inOptometry and vision science Vol. 93; no. 3; pp. 227 - 234
Main Authors Naidoo, Kovin S., Leasher, Janet, Bourne, Rupert R., Flaxman, Seth R., Jonas, Jost B., Keeffe, Jill, Limburg, Hans, Pesudovs, Konrad, Price, Holly, White, Richard A., Wong, Tien Y., Taylor, Hugh R., Resnikoff, Serge
Format Journal Article
LanguageEnglish
Published United States American Academy of Optometry 01.03.2016
Subjects
Online AccessGet full text
ISSN1040-5488
1538-9235
DOI10.1097/OPX.0000000000000796

Cover

Loading…
Abstract The purpose of this systematic review was to estimate worldwide the number of people with moderate and severe visual impairment (MSVI; presenting visual acuity <6/18, ≥3/60) or blindness (presenting visual acuity <3/60) due to uncorrected refractive error (URE), to estimate trends in prevalence from 1990 to 2010, and to analyze regional differences. The review focuses on uncorrected refractive error which is now the most common cause of avoidable visual impairment globally. The systematic review of 14,908 relevant manuscripts from 1990 to 2010 using Medline, Embase, and WHOLIS yielded 243 high-quality, population-based cross-sectional studies which informed a meta-analysis of trends by region. The results showed that in 2010, 6.8 million (95% confidence interval [CI]4.7–8.8 million) people were blind (7.9% increase from 1990) and 101.2 million (95% CI87.88–125.5 million) vision impaired due to URE (15% increase since 1990), while the global population increased by 30% (1990–2010). The all-age age-standardized prevalence of URE blindness decreased 33% from 0.2% (95% CI0.1–0.2%) in 1990 to 0.1% (95% CI0.1–0.1%) in 2010, whereas the prevalence of URE MSVI decreased 25% from 2.1% (95% CI1.6–2.4%) in 1990 to 1.5% (95% CI1.3–1.9%) in 2010. In 2010, URE contributed 20.9% (95% CI15.2–25.9%) of all blindness and 52.9% (95% CI47.2–57.3%) of all MSVI worldwide. The contribution of URE to all MSVI ranged from 44.2 to 48.1% in all regions except in South Asia which was at 65.4% (95% CI62–72%). We conclude that in 2010, uncorrected refractive error continues as the leading cause of vision impairment and the second leading cause of blindness worldwide, affecting a total of 108 million people or 1 in 90 persons.
AbstractList The purpose of this systematic review was to estimate worldwide the number of people with moderate and severe visual impairment (MSVI; presenting visual acuity <6/18, ≥3/60) or blindness (presenting visual acuity <3/60) due to uncorrected refractive error (URE), to estimate trends in prevalence from 1990 to 2010, and to analyze regional differences. The review focuses on uncorrected refractive error which is now the most common cause of avoidable visual impairment globally. : The systematic review of 14,908 relevant manuscripts from 1990 to 2010 using Medline, Embase, and WHOLIS yielded 243 high-quality, population-based cross-sectional studies which informed a meta-analysis of trends by region. The results showed that in 2010, 6.8 million (95% confidence interval [CI]: 4.7-8.8 million) people were blind (7.9% increase from 1990) and 101.2 million (95% CI: 87.88-125.5 million) vision impaired due to URE (15% increase since 1990), while the global population increased by 30% (1990-2010). The all-age age-standardized prevalence of URE blindness decreased 33% from 0.2% (95% CI: 0.1-0.2%) in 1990 to 0.1% (95% CI: 0.1-0.1%) in 2010, whereas the prevalence of URE MSVI decreased 25% from 2.1% (95% CI: 1.6-2.4%) in 1990 to 1.5% (95% CI: 1.3-1.9%) in 2010. In 2010, URE contributed 20.9% (95% CI: 15.2-25.9%) of all blindness and 52.9% (95% CI: 47.2-57.3%) of all MSVI worldwide. The contribution of URE to all MSVI ranged from 44.2 to 48.1% in all regions except in South Asia which was at 65.4% (95% CI: 62-72%). : We conclude that in 2010, uncorrected refractive error continues as the leading cause of vision impairment and the second leading cause of blindness worldwide, affecting a total of 108 million people or 1 in 90 persons.
The purpose of this systematic review was to estimate worldwide the number of people with moderate and severe visual impairment (MSVI; presenting visual acuity <6/18, ≥3/60) or blindness (presenting visual acuity <3/60) due to uncorrected refractive error (URE), to estimate trends in prevalence from 1990 to 2010, and to analyze regional differences. The review focuses on uncorrected refractive error which is now the most common cause of avoidable visual impairment globally. The systematic review of 14,908 relevant manuscripts from 1990 to 2010 using Medline, Embase, and WHOLIS yielded 243 high-quality, population-based cross-sectional studies which informed a meta-analysis of trends by region. The results showed that in 2010, 6.8 million (95% confidence interval [CI]4.7–8.8 million) people were blind (7.9% increase from 1990) and 101.2 million (95% CI87.88–125.5 million) vision impaired due to URE (15% increase since 1990), while the global population increased by 30% (1990–2010). The all-age age-standardized prevalence of URE blindness decreased 33% from 0.2% (95% CI0.1–0.2%) in 1990 to 0.1% (95% CI0.1–0.1%) in 2010, whereas the prevalence of URE MSVI decreased 25% from 2.1% (95% CI1.6–2.4%) in 1990 to 1.5% (95% CI1.3–1.9%) in 2010. In 2010, URE contributed 20.9% (95% CI15.2–25.9%) of all blindness and 52.9% (95% CI47.2–57.3%) of all MSVI worldwide. The contribution of URE to all MSVI ranged from 44.2 to 48.1% in all regions except in South Asia which was at 65.4% (95% CI62–72%). We conclude that in 2010, uncorrected refractive error continues as the leading cause of vision impairment and the second leading cause of blindness worldwide, affecting a total of 108 million people or 1 in 90 persons.
Author Keeffe, Jill
Limburg, Hans
Resnikoff, Serge
Taylor, Hugh R.
Jonas, Jost B.
Pesudovs, Konrad
White, Richard A.
Wong, Tien Y.
Bourne, Rupert R.
Price, Holly
Leasher, Janet
Naidoo, Kovin S.
Flaxman, Seth R.
AuthorAffiliation OD, PhD †OD, MPH ‡FRCOphth, MD §BA ∥MD PhD ††MD, PhD ‡‡BSc, PhD §§AC, MD African Vision Research Institute, University of KwaZulu-Natal, South Africa (KSN); Brien Holden Vision Institute, Sydney, Australia (KSN, SR); School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia (KSN, SR); Nova Southeastern University, Ft. Lauderdale, Florida (JL); Vision & Eye Research Unit, Anglia Ruskin University, Cambridge, United Kingdom (RRB, HP); School of Computer Science & Heinz College, Carnegie Mellon University, Pittsburgh, Pennsylvania (SRF); Department of Ophthalmology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany (JBJ); L. V. Prasad Eye Institute, Hyderabad, India (JK); Health Information Services, Grootebroek, Netherlands (HL); NHMRC Centre for Clinical Eye Research, Flinders University, Adelaide, South Australia, Australia (KP); Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public
AuthorAffiliation_xml – name: OD, PhD †OD, MPH ‡FRCOphth, MD §BA ∥MD PhD ††MD, PhD ‡‡BSc, PhD §§AC, MD African Vision Research Institute, University of KwaZulu-Natal, South Africa (KSN); Brien Holden Vision Institute, Sydney, Australia (KSN, SR); School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia (KSN, SR); Nova Southeastern University, Ft. Lauderdale, Florida (JL); Vision & Eye Research Unit, Anglia Ruskin University, Cambridge, United Kingdom (RRB, HP); School of Computer Science & Heinz College, Carnegie Mellon University, Pittsburgh, Pennsylvania (SRF); Department of Ophthalmology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany (JBJ); L. V. Prasad Eye Institute, Hyderabad, India (JK); Health Information Services, Grootebroek, Netherlands (HL); NHMRC Centre for Clinical Eye Research, Flinders University, Adelaide, South Australia, Australia (KP); Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway (RAW); Singapore Eye Research Institute, Singapore (TYW); and Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia (HRT)
Author_xml – sequence: 1
  givenname: Kovin
  surname: Naidoo
  middlename: S.
  fullname: Naidoo, Kovin S.
  organization: OD, PhD †OD, MPH ‡FRCOphth, MD §BA ∥MD PhD ††MD, PhD ‡‡BSc, PhD §§AC, MD African Vision Research Institute, University of KwaZulu-Natal, South Africa (KSN); Brien Holden Vision Institute, Sydney, Australia (KSN, SR); School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia (KSN, SR); Nova Southeastern University, Ft. Lauderdale, Florida (JL); Vision & Eye Research Unit, Anglia Ruskin University, Cambridge, United Kingdom (RRB, HP); School of Computer Science & Heinz College, Carnegie Mellon University, Pittsburgh, Pennsylvania (SRF); Department of Ophthalmology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany (JBJ); L. V. Prasad Eye Institute, Hyderabad, India (JK); Health Information Services, Grootebroek, Netherlands (HL); NHMRC Centre for Clinical Eye Research, Flinders University, Adelaide, South Australia, Australia (KP); Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway (RAW); Singapore Eye Research Institute, Singapore (TYW); and Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia (HRT)
– sequence: 2
  givenname: Janet
  surname: Leasher
  fullname: Leasher, Janet
– sequence: 3
  givenname: Rupert
  surname: Bourne
  middlename: R.
  fullname: Bourne, Rupert R.
– sequence: 4
  givenname: Seth
  surname: Flaxman
  middlename: R.
  fullname: Flaxman, Seth R.
– sequence: 5
  givenname: Jost
  surname: Jonas
  middlename: B.
  fullname: Jonas, Jost B.
– sequence: 6
  givenname: Jill
  surname: Keeffe
  fullname: Keeffe, Jill
– sequence: 7
  givenname: Hans
  surname: Limburg
  fullname: Limburg, Hans
– sequence: 8
  givenname: Konrad
  surname: Pesudovs
  fullname: Pesudovs, Konrad
– sequence: 9
  givenname: Holly
  surname: Price
  fullname: Price, Holly
– sequence: 10
  givenname: Richard
  surname: White
  middlename: A.
  fullname: White, Richard A.
– sequence: 11
  givenname: Tien
  surname: Wong
  middlename: Y.
  fullname: Wong, Tien Y.
– sequence: 12
  givenname: Hugh
  surname: Taylor
  middlename: R.
  fullname: Taylor, Hugh R.
– sequence: 13
  givenname: Serge
  surname: Resnikoff
  fullname: Resnikoff, Serge
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26905537$$D View this record in MEDLINE/PubMed
BookMark eNqNkMtOFzEUhxuDkYu-gTFdunCwt-nFnSIgCQnGiLprOtMzodpp_7YdiTvewTf0SRwEEsPKszmXfL-z-HbRVsoJEHpKyT4lRr08e_9ln_xbysgHaIf2XHeG8X5rnYkgXS-03ka7tX4lhCrey0dom0lD-p6rHfT5OObBRfwp1JATPpk3LpQZUsMuefwmhuQT1IrfLoBbxudpzKXA2MDjDzAVN7bwA_BhKbm8wNQY8vvqFyOUPEYPJxcrPLnte-j86PDjwbvu9Oz45OD1aTdyoXmnBjGAdMR475znegTqnaCe9b1iXElPpdNCE6MnxgY-MeWMoHpwHCQh3PE99Pzm76bk7wvUZudQR4jRJchLtVRJTaXShqzos1t0GWbwdlPC7MpPeydjBV7dAGPJtRaY7Biaa6uXVlyIlhJ7bd6u5u1982tY3Avf_f-_2GWODUr9FpdLKPYCXGwXf3HJmehWpZLwdeuuT5z_AYV8k4c
CitedBy_id crossref_primary_10_1136_bjophthalmol_2019_315103
crossref_primary_10_1038_s41746_019_0154_5
crossref_primary_10_1145_3550283
crossref_primary_10_1177_11206721231184544
crossref_primary_10_1016_j_ajo_2018_09_020
crossref_primary_10_1080_08164622_2023_2202305
crossref_primary_10_1097_ICL_0000000000000907
crossref_primary_10_1371_journal_pone_0215329
crossref_primary_10_1080_08164622_2022_2107891
crossref_primary_10_1167_tvst_14_1_8
crossref_primary_10_4103_joco_joco_337_21
crossref_primary_10_1097_OPX_0000000000001308
crossref_primary_10_4103_joco_joco_56_21
crossref_primary_10_1038_s41433_020_1009_7
crossref_primary_10_1097_OPX_0000000000001143
crossref_primary_10_1097_OPX_0000000000001661
crossref_primary_10_1016_j_measurement_2018_02_021
crossref_primary_10_2139_ssrn_3901777
crossref_primary_10_4103_djo_djo_70_21
crossref_primary_10_4103_pajo_pajo_5_24
crossref_primary_10_4103_ijo_IJO_982_17
crossref_primary_10_3928_1081597X_20170310_01
crossref_primary_10_1038_s41433_019_0469_0
crossref_primary_10_1016_j_ajo_2024_11_012
crossref_primary_10_1016_j_joco_2017_05_006
crossref_primary_10_1186_s12886_023_02994_2
crossref_primary_10_1016_j_joco_2017_05_004
crossref_primary_10_1186_s12982_025_00481_1
crossref_primary_10_1080_02713683_2018_1485953
crossref_primary_10_4103_ijo_IJO_3503_20
crossref_primary_10_3389_fpsyg_2022_954328
crossref_primary_10_7759_cureus_37834
crossref_primary_10_1111_cxo_12646
crossref_primary_10_1111_ceo_12954
crossref_primary_10_1371_journal_pone_0211186
crossref_primary_10_1136_bjophthalmol_2018_312573
crossref_primary_10_1080_08820538_2018_1539182
crossref_primary_10_1136_bjo_2023_323468
crossref_primary_10_1007_s40123_023_00842_6
crossref_primary_10_1097_ICU_0000000000000376
crossref_primary_10_1007_s10792_024_03178_7
crossref_primary_10_1016_j_jfo_2024_104381
crossref_primary_10_1097_MD_0000000000027758
crossref_primary_10_1080_09286586_2017_1376338
crossref_primary_10_1117_1_OE_61_12_121809
crossref_primary_10_1371_journal_pone_0271313
crossref_primary_10_1186_s12886_021_01996_2
crossref_primary_10_24875_RMO_M21000201
crossref_primary_10_1186_s12889_024_20387_y
crossref_primary_10_1111_opo_13172
crossref_primary_10_2144_fsoa_2022_0075
crossref_primary_10_18502_jovr_v17i2_10794
crossref_primary_10_7759_cureus_29925
crossref_primary_10_1016_j_joco_2017_08_009
crossref_primary_10_1016_j_puhe_2017_09_004
crossref_primary_10_1111_cxo_12650
crossref_primary_10_4103_ijo_IJO_2098_21
crossref_primary_10_61919_jhrr_v4i3_1530
crossref_primary_10_4236_ojoph_2024_143030
crossref_primary_10_1097_ICU_0000000000000548
crossref_primary_10_1097_OPX_0000000000002000
crossref_primary_10_1371_journal_pone_0313220
crossref_primary_10_1007_s40123_021_00360_3
crossref_primary_10_1097_APO_0000000000000488
crossref_primary_10_18502_jovr_v17i1_10173
crossref_primary_10_1177_0145482X211016570
crossref_primary_10_1371_journal_pone_0162229
crossref_primary_10_4103_ijo_IJO_2724_20
crossref_primary_10_1186_s12886_021_02134_8
crossref_primary_10_1016_j_optom_2022_07_003
crossref_primary_10_3389_fmed_2023_1141438
crossref_primary_10_1016_S2468_2667_20_30254_1
crossref_primary_10_4102_aveh_v75i1_355
crossref_primary_10_1186_s12889_021_11648_1
crossref_primary_10_1146_annurev_vision_091718_015027
crossref_primary_10_1016_j_joco_2017_04_003
crossref_primary_10_3389_fmed_2021_759767
crossref_primary_10_1186_s12886_017_0561_9
crossref_primary_10_1016_j_survophthal_2023_07_001
crossref_primary_10_21516_2072_0076_2022_15_2_supplement_98_103
crossref_primary_10_1080_09286586_2021_1919311
crossref_primary_10_1016_j_joco_2018_12_001
crossref_primary_10_1186_s12886_021_02145_5
crossref_primary_10_1186_s13584_019_0339_z
crossref_primary_10_1186_s13584_025_00667_7
crossref_primary_10_1186_s12909_019_1738_0
crossref_primary_10_1136_bjo_2022_322123
crossref_primary_10_1016_S0140_6736_18_33209_4
crossref_primary_10_3390_healthcare10020405
crossref_primary_10_1371_journal_pone_0191199
crossref_primary_10_1016_j_aopr_2024_06_005
crossref_primary_10_4103_JOCO_JOCO_224_20
crossref_primary_10_4103_JOCO_JOCO_100_20
crossref_primary_10_1016_j_clae_2021_101518
crossref_primary_10_3389_fmed_2021_753257
crossref_primary_10_1136_bjophthalmol_2021_318828
crossref_primary_10_1186_s12886_024_03372_2
crossref_primary_10_1007_s10384_022_00900_9
crossref_primary_10_1001_jamaophthalmol_2018_4229
crossref_primary_10_1016_j_jaapos_2021_07_013
crossref_primary_10_1371_journal_pone_0192055
crossref_primary_10_1016_j_ophtha_2022_05_020
crossref_primary_10_1016_j_joco_2017_02_007
crossref_primary_10_1007_s00038_017_1000_7
crossref_primary_10_1016_j_joco_2018_08_001
crossref_primary_10_1016_j_puhe_2020_10_028
crossref_primary_10_1371_journal_pone_0240933
crossref_primary_10_1097_OPX_0000000000002054
crossref_primary_10_1016_j_cub_2024_02_052
crossref_primary_10_4102_aveh_v79i1_534
crossref_primary_10_1371_journal_pone_0268800
crossref_primary_10_1167_iovs_61_10_11
crossref_primary_10_3389_fnut_2022_1038963
crossref_primary_10_4102_aveh_v77i1_392
crossref_primary_10_1111_cxo_13025
crossref_primary_10_3389_fneur_2025_1465444
crossref_primary_10_1016_j_yaoo_2021_04_020
crossref_primary_10_18231_j_ijceo_2021_085
crossref_primary_10_36320_ajb_v14_i2_11349
crossref_primary_10_1080_08164622_2021_1993057
crossref_primary_10_1097_ICL_0000000000000360
crossref_primary_10_1097_OPX_0000000000001998
crossref_primary_10_4103_1319_4534_301297
crossref_primary_10_1016_j_aopr_2021_100010
crossref_primary_10_1136_bjophthalmol_2018_312428
crossref_primary_10_1001_jamaophthalmol_2020_1677
crossref_primary_10_1007_s10384_021_00828_6
crossref_primary_10_1097_OPX_0000000000001356
crossref_primary_10_4103_ijo_IJO_1333_17
crossref_primary_10_4103_sjhs_sjhs_81_22
crossref_primary_10_4103_ijo_IJO_869_16
crossref_primary_10_4103_sjopt_sjopt_46_21
crossref_primary_10_2147_OPTH_S440578
Cites_doi 10.1167/iovs.03-0283
10.1016/j.ophtha.2013.05.025
10.1016/S0002-9394(99)00453-5
10.1016/S0140-6736(12)61689-4
10.2471/BLT.07.041210
10.1016/S0002-9394(99)00454-7
10.1016/S0002-9394(99)00452-3
10.1076/opep.8.1.39.1540
10.4103/0974-9233.80695
10.4103/0301-4738.100543
10.1016/S2214-109X(13)70113-X
10.2471/BLT.08.055673
ContentType Journal Article
Copyright 2016 American Academy of Optometry
Copyright_xml – notice: 2016 American Academy of Optometry
CorporateAuthor Vision Loss Expert Group of the Global Burden of Disease Study
CorporateAuthor_xml – name: Vision Loss Expert Group of the Global Burden of Disease Study
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1097/OPX.0000000000000796
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1538-9235
EndPage 234
ExternalDocumentID 26905537
10_1097_OPX_0000000000000796
00006324-201603000-00003
Genre Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Journal Article
GroupedDBID ---
-~X
.GJ
.Z2
0R~
123
4Q1
4Q2
4Q3
53G
5VS
71W
AAAAV
AAHPQ
AAIQE
AAMTA
AARTV
AASCR
AAWTL
ABASU
ABBUW
ABDIG
ABDPE
ABJNI
ABPXF
ABVCZ
ABXRP
ABXVJ
ABZAD
ABZZY
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACNCT
ACWDW
ACWRI
ACXJB
ACXNZ
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AEETU
AENEX
AFBFQ
AFDTB
AFFNX
AFUWQ
AHQNM
AHRYX
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BQLVK
BS7
C45
CS3
DIK
DIWNM
DU5
DUNZO
E.X
EBS
EEVPB
EJD
EX3
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IN~
JF9
JG8
JK3
JK8
K8S
KD2
L-C
N~M
O9-
OAG
OAH
OCUKA
ODA
OK1
OLG
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
P6G
R58
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
V2I
VVN
W3M
WH7
WOQ
WOW
X3V
X3W
XOL
XXN
XYM
YFH
ZB8
ZFV
ZXP
ZZMQN
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3483-7b4be6a09ddaad38ce1da41d25572376d16a848098f22b3f27a9418ba3e6003a3
ISSN 1040-5488
IngestDate Fri Jul 11 15:06:58 EDT 2025
Sat Jun 28 01:34:47 EDT 2025
Tue Jul 01 03:22:56 EDT 2025
Thu Apr 24 22:58:10 EDT 2025
Fri May 16 04:02:16 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3483-7b4be6a09ddaad38ce1da41d25572376d16a848098f22b3f27a9418ba3e6003a3
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Review-1
ObjectType-Article-3
ObjectType-Undefined-4
PMID 26905537
PQID 1768167890
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1768167890
pubmed_primary_26905537
crossref_citationtrail_10_1097_OPX_0000000000000796
crossref_primary_10_1097_OPX_0000000000000796
wolterskluwer_health_00006324-201603000-00003
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-March
2016-03-00
2016-Mar
20160301
PublicationDateYYYYMMDD 2016-03-01
PublicationDate_xml – month: 03
  year: 2016
  text: 2016-March
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Optometry and vision science
PublicationTitleAlternate Optom Vis Sci
PublicationYear 2016
Publisher American Academy of Optometry
Publisher_xml – name: American Academy of Optometry
References Maul (R9-3-20210202) 2000; 129
Murthy (R12-3-20210202) 2002; 43
Pokharel (R7-3-20210202) 2000; 129
Naidoo (R3-3-20210202) 2012; 60
Mganga (R19-3-20210202) 2011; 18
Abou-Gareeb (R18-3-20210202) 2001; 8
Bourne (R2-3-20210202) 2013; 1
Stevens (R13-3-20210202) 2013; 120
Zhao (R8-3-20210202) 2000; 129
Dandona (R11-3-20210202) 2002; 43
Naidoo (R10-3-20210202) 2003; 44
Dandona (R17-3-20210202) 2006; 4
Resnikoff (R1-3-20210202) 2008; 86
Smith (R4-3-20210202) 2009; 87
Murray (R15-3-20210202) 2012; 380
References_xml – volume: 44
  start-page: 3764
  year: 2003
  ident: R10-3-20210202
  article-title: Refractive error and visual impairment in African children in South Africa.
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.03-0283
– volume: 4
  start-page: 6
  year: 2006
  ident: R17-3-20210202
  article-title: What is the global burden of visual impairment BMC M
  publication-title: ed
– volume: 120
  start-page: 2377
  year: 2013
  ident: R13-3-20210202
  article-title: Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010.
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2013.05.025
– volume: 129
  start-page: 436
  year: 2000
  ident: R7-3-20210202
  article-title: Refractive Error Study in Children: results from Mechi Zone, Nepal.
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(99)00453-5
– volume: 380
  start-page: 2197
  year: 2012
  ident: R15-3-20210202
  article-title: Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)61689-4
– volume: 86
  start-page: 63
  year: 2008
  ident: R1-3-20210202
  article-title: Global magnitude of visual impairment caused by uncorrected refractive errors in 2004.
  publication-title: Bull World Health Organ
  doi: 10.2471/BLT.07.041210
– volume: 129
  start-page: 445
  year: 2000
  ident: R9-3-20210202
  article-title: Refractive Error Study in Children: results from La Florida, Chile.
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(99)00454-7
– volume: 43
  start-page: 615
  year: 2002
  ident: R11-3-20210202
  article-title: Refractive error in children in a rural population in India.
  publication-title: Invest Ophthalmol Vis Sci
– volume: 129
  start-page: 427
  year: 2000
  ident: R8-3-20210202
  article-title: Refractive Error Study in Children: results from Shunyi District, China.
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(99)00452-3
– volume: 43
  start-page: 623
  year: 2002
  ident: R12-3-20210202
  article-title: Refractive error in children in an urban population in New Delhi.
  publication-title: Invest Ophthalmol Vis Sci
– volume: 8
  start-page: 39
  year: 2001
  ident: R18-3-20210202
  article-title: Gender and blindness: a meta-analysis of population-based prevalence surveys.
  publication-title: Ophthalmic Epidemiol
  doi: 10.1076/opep.8.1.39.1540
– volume: 18
  start-page: 98
  year: 2011
  ident: R19-3-20210202
  article-title: Overcoming gender inequity in prevention of blindness and visual impairment in Africa.
  publication-title: Middle East Afr J Ophthalmol
  doi: 10.4103/0974-9233.80695
– volume: 60
  start-page: 432
  year: 2012
  ident: R3-3-20210202
  article-title: Uncorrected refractive errors.
  publication-title: Indian J Ophthalmol
  doi: 10.4103/0301-4738.100543
– volume: 1
  start-page: e339
  year: 2013
  ident: R2-3-20210202
  article-title: Causes of vision loss worldwide, 1990-2010: a systematic analysis.
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(13)70113-X
– volume: 87
  start-page: 431
  year: 2009
  ident: R4-3-20210202
  article-title: Potential lost productivity resulting from the global burden of uncorrected refractive error.
  publication-title: Bull World Health Organ
  doi: 10.2471/BLT.08.055673
SSID ssj0017356
Score 2.5067387
SecondaryResourceType review_article
Snippet The purpose of this systematic review was to estimate worldwide the number of people with moderate and severe visual impairment (MSVI; presenting visual acuity...
SourceID proquest
pubmed
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 227
SubjectTerms Adult
Blindness - epidemiology
Blindness - etiology
Cross-Sectional Studies
Female
Global Health - statistics & numerical data
Humans
Male
Middle Aged
Persons with Visual Disabilities - statistics & numerical data
Prevalence
Refractive Errors - complications
Refractive Errors - epidemiology
Refractive Errors - therapy
Vision, Low - epidemiology
Vision, Low - etiology
Visual Acuity
Title Global Vision Impairment and Blindness Due to Uncorrected Refractive Error, 1990–2010
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00006324-201603000-00003
https://www.ncbi.nlm.nih.gov/pubmed/26905537
https://www.proquest.com/docview/1768167890
Volume 93
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSAiEJu4rDGQk3ka2OHac5JHdNDbGEFpR3yI7dsW0ramyFCR-Pcd27GQXxKUPVZW0juTz9eSck_N9B6G3FHJkwmMVaVnkEaMijQqt04jqWHCVyaJKDVH48BPfG7P9STrpW4Isu6SV69XPG3kl_2NVOAZ2NSzZf7BsWBQOwGewL7yDheH9r2zsBPvXvlp-uBH6FSdNaBrfhABSWUe2vbDzMcZGstI4OG0oiVNLj_quwRM2LmUncMuIzGPrYcB6NG_rc902TqbJMdHXuttmKCSLE1XbkuuBqU_01dSPWvjB6vti1lOtN0Ml9ctirpu271rcPROhJqvbb92JripBeN-Wta4HnjRxWiTe1bphiB2k6NBvOoGAa_7c6QQffZ44nUn_ytwU3IGJ5-fWxgkk-2nqZGSu6Gj7U7fRnQRSCjPtYvvDQXjilNGUe2plkW3cdEkjHN0tcjmKuZaa3EcPftSm2-Hi1JIdBiHL8UO03OUa-L0DziN0S88eo7uHXTfFEzR2-MEOP7jHDwZb44AfDPjBbY0H-ME9frDFzzsc0PMUjXd3jrf2om7MRlRRltMok0xqLuJCKSEUzStNlGBEQbKZmZ4pRbjIWR4X-TRJJJ0mmSgYyaWgGqJlKugztDSrZ3oF4SlNlWIKUtY4ZzTOJYRCFYS4SnKhVcpHiPptK6tOg96MQjkrfS8E7Ht5dd9HKAq_mjsNlj98_423SAnO0jwBA4zXi4uSQHJNuOF-j9BzZ6qwojctXO2S7UpHSLZXMbMNzFZyuDU6RYaYvvjtSi_Rvf6vsYqW2mahX0EI28rXFnu_ADL_kD8
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+Vision+Impairment+and+Blindness+Due+to+Uncorrected+Refractive+Error%2C+1990-2010&rft.jtitle=Optometry+and+vision+science&rft.au=Naidoo%2C+Kovin+S&rft.au=Leasher%2C+Janet&rft.au=Bourne%2C+Rupert+R&rft.au=Flaxman%2C+Seth+R&rft.date=2016-03-01&rft.eissn=1538-9235&rft.volume=93&rft.issue=3&rft.spage=227&rft_id=info:doi/10.1097%2FOPX.0000000000000796&rft_id=info%3Apmid%2F26905537&rft.externalDocID=26905537
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1040-5488&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1040-5488&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1040-5488&client=summon